615 results about "Eczematous rash" patented technology

A cellular constituent is lysed from, produced by and / or isolated from one or more bacteria from the genus Bacteroides, and the cellular constituent, a derivative thereof, and / or one or more bacteria from the genus Bacteroides, or a modified form thereof, is employed in compositions and methods for modulating an inflammatory response. Such methods include methods of treating, delaying the onset of or reducing the symptoms of one or more inflammatory conditions / diseases, including corporal or gastrointestinal inflammation, for example, Irritable Bowel Syndrome, Crohn's Disease, or colitis, and / or associated diseases such diabetes, asthma, multiple sclerosis, cancer, rheumatoid arthritis, gingivitis, atopic diseases, for example, hay fever, food allergies, eczema, rhinitis, dermatitis, conjunctivitis, atopic syndrome and keratosis pelaris, ocular inflammatory disease, strokes, cardiovascular disease, depression, atherosclerosis and hypertension, and comprise administering a composition comprising one or more natural and / or modified bacteria of the genus Bacteroides, and / or a cellular constituent lysed from, produced by, or isolated from one or more natural and / or modified bacteria from the genus Bacteroides, or a derivative thereof.

This invention relates to certain sugar esters of phytosterols of formula (I). These esters are useful for topical application, and for the treatment of skin condition, including age spots, acne, loss of cellular antioxidants, collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles including fine lines, oxidation, damage from radiation, malfunction of matrix metalloproteases, malfunction of tyrosinases, damage from free radicals, damage from UV, dry skin, xerosis, ichthyosis, dandruff, brownish spots, keratoses, melasma, lentigines, liver spots, pigmented spots, dark circles under the eyes, skin pigmentation including darkened skin, blemishes, oily skin, warts, eczema, pruritic skin, psoriasis, inflammatory dermatoses, topical inflammation, disturbed keratinization, skin changes associated with aging, nail or skin requiring cleansers, conditioning or treatment, and hair or scalp requiring shampooing or conditioning, and combinations thereof;Wherein,n=0, 1, 2, or 3; andR=H, —CH2OH, —CH(OH)—CH2OH, —CH(OH)—CH(OH)—CH2OH; andR1=Substituent selected from a sapogenin, steroid, or terpenoid.

The invention relates to the stimulation of the activity of an isoform of lysyl oxidase, and more particularly of the LOX (lysyl oxidase) isoform. The invention relates notably to a screening method of an active principle which regulates elastogenesis in cases of pathological, disorganized and / or non-functional elastogenesis, as in cases of fibrosis, of solar elastosis, of stretch marks, and / or of dystrophic scars; and / or in cases of some eczematous pathologies. The aim of the invention is mainly to provide such a screening method so as to provide compositions enabling the elastogenesis in the cases cited to be regulated.

Synergetic compounded medication formula for the treatment of psoriasis, seborrhea, dermatitis, dandruff, eczema, acne, and other skin disorders. The present invention is to provide regenerative treatment of skin disorders recurrent in all areas of the body. The invention of this disclosure uses a well-known corticosteroid as an active ingredient, namely Triamcinolone acetonide, which when used in combination with a special formula is effective, easy to use, and less expensive than similar products available with a prescription in the market. A method for administering said composition to inhibit proliferation of psoriatic cell populations in the epidermis is disclosed

The invention discloses a hyaluronic acid dressing and a preparation method thereof. The dressing comprises the following components in percentage by mass: 0.01-0.3% of medium-molecular-weight hyaluronic acid, 0.01-0.5% of small-molecular-weight hyaluronic acid, 0.03-1% of allantoin, 0.1-1% of Carbomer, 2-5% of sorbitol, 0.2-1% of trehalose, 0.7-2.5% of witch hazel distillate, 0.1-0.5% of D-panthenol, 0.05-0.15% of alpha-bisabolol, 0.2-1.0% of oat glucan, 2-10% of glycerinum, 0.06-1% of water-soluble silicon wax, 0.05-0.9% of an antalkali, 0.004-0.2% of 2-methyl-4-isothiazoline-3-one, 0.05-0.4% of phenoxyethanol, 0.005-0.05% of pentanediol, 0.01-0.06% of octylene glycol, 0.025-0.5% of methylparaben and the balance of water. The dressing disclosed by the invention is capable of permeating into the deep layers of the skin to remove excessive free radicals, promoting the generations of blood vessels, and accelerating the union of wounds, in particular, acnes, eczematous dermatitis, photorejuvenation postoperation repair and the like.

The invention relates to an external traditional Chinese medicine for treating skin diseases. The medicine provided by the invention is composed of paste and tincture, wherein the paste is composed of radix sophorae flavescentis, Chinese violet, coptis, phellodendron bark, rhubarb, cortex dictamni, lithospermum, manyleaf paris rhizome, fructus cnidii, herba patriniae, ampelopsis japonica, fructus kochiae, cynanchum paniculatum, dahurian angelica root, angelica, myrrh, arborvitae tops, pseudo-ginseng, nidus vespae, borax, calamine, vaseline, lanolin and octadecanol; and the tincture is composed of stemona, desmodium, polygonum cuspidatum, phryma leptostachya, garden burnet, golden larch bark, nepal dock root, gallnut, cynanchum paniculatum, felwort, benzoic acid, salicylic acid and 75% ethanol. The external traditional Chinese medicine provided by the invention has the functions of clearing away heat and toxic materials, cooling blood, prompting blood flow, removing beverage, dispersing blood stasis, dispelling wind, eliminating dampness, restraining and sterilizing bacteria, eliminating swelling, relieving itching, dispelling the wind, moistening dryness and killing pests, and the external traditional Chinese medicine has good curative effect on such skin diseases as psoriasis, eczema, dermatitis, tinea corporis, tinea pedis, tinea versicolor and scabies.

This invention discloses a method of use for a topical herbal formulation alone or in combination with oral administration of niacin (preferably a flush preparation) to prevent and / or treat dyshidrosis (pompholyx) and related skin diseases. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (Juglans nigra), wormwood (Artemisia absinthium), tumeric rhizome (Curcuma longa), garlic (Allium sativum), two or more herbal antibacterial agents from the group consisting of chamomile (Matricaria Chamomile), licorice root (Glycyrrhiza glabra), St Johns wort (Hypericum perforatum), clove (Syzygium aromaticum), nutmeg (Myristica fragans), ginger (Zingiber officinale), frankincense (Boswellia carteri) and myrrh (Commiphora molmol), further combined with aloe vera and niacin.

A composite medicine with skin target for treating pointed condyloma, viral or fungal infection of skin, and eczema is prepared from oil, surfactant, surfactant assistant, osmotic promoter, active medicine and water through proportional mixing, and adding gel matrix.

The present invention provides unique, efficacious, inexpensive, safe, reliable, convenient, minimally bitter, skin protecting and penetrating, easy-to-administer base compositions and active agent-containing compositions, such as those including hydrocortisone, and related production and topical application methods, for treating the skin of mammals for a wide variety of different dermatologic conditions, disorders and diseases, such as inflammation, redness, cracking, insect bites, dryness, allergic reactions, trauma, irritant dermatitis, perleche, contact dermatitis, psoriasis, eczema, seborrheic dermatitis, acne excoriate, xerosis, eczema craquele, stasis dermatitis, disease related conditions and dryness from medications such as isotretinoin, acitretin and lipid lowering agents. This is effected by topically administering, or otherwise applying, effective amounts of the compositions thereto in forms that not only address the skin and mucosa of the mouth and lips, but also of the rest of the body and, in particular, areas where other topical balms containing hydrocortisone and other active ingredients have not been developed or marketed. Additionally, the flavoring addition to this product, and the base wherein the active ingredient(s) reside, affords a significantly better tasting, and less bitter, composition, thereby allowing a more pleasant experience and better compliance by patients. Larger sized stick formulation(s) allow for more applicability of the product, and more usefulness thereof, in various areas, and mucosal skin, of the body. The compositions include a unique formulation of FANCOL VB, Natunola Castor 1023, Finsolv TN, bees wax and, optionally, one or a plurality of plant or plant seed oils, fatty alcohols, fats and flavorings, in desirable weight percents thereof, in various forms, and preferably in the form of a solid roll-on stick present in a variety of sizes.

The invention discloses a preparation for treating eczema. The preparation is prepared from the following raw materials of liquorice, moutan bark, raw rehmannia root, talc, rhizoma smilacis glabrae, fleece-flower root, peach kernel, fructus forsythiae, honeysuckle, Chinese angelica, poria, zhaici, baikuicai, periostracum cicada, polyporus umbellatus, fructus cnidii, cortex dictamni, divaricate saposhnikovia root, sichuan lovage rhizome, safflower, salviae miltiorrhizae, radix paeoniae alba, astragalus membranaceus, radix sophorae flavescentis, prepared rehmannia, fructus kochiae and burdock, as well as external auxiliary lotion and external auxiliary application. The invention also discloses a method for preparing the preparation for treating eczema. The preparation is prepared from natural traditional Chinese medicinal herbs, simple in components and reasonable in proportion, applies the theory that five drugs penetrating into organs play effect in channels, a comprehensive treatment of internal administration, external lotion and external application is adopted, regulation is performed by internal and external means at the same time, so that the curative effect and the heal rate can be further improved. The preparation has the advantages of high heal rate and extremely good curative effect when being used for treating eczematous dermatitis, rhagadia, atopic dermatitis and other various eczema skin diseases.

The invention discloses a traditional Chinese medicine active matter composition and application thereof in cosmetics. The traditional Chinese medicine active matter composition comprises a shrubby sophora extract, a licorice extract, a wild mint herb extract, a coptis root extract, a scutellaria baicalensis extract, a white peony root extract, a langehead atractylodes rhizome extract and a portulaca oleracea extract; the natural plant extracts, water and glycerin are compounded proportionally so as to prepare a natural traditional Chinese medicine active matter plant composition; the composition is stable in physicochemical properties, is less prone to crystallization and can be added in the cosmetics easily; moreover, the efficacy assessment proves that when added in the cosmetics, the composition has the efficacies of inhibiting and improving symptoms, such as dry skin, reddening of skin, skin itch and eczema; the natural plant extract combination can be applied to emulsion type cream or lotions, and can also be added in various products, such as skin care lotions, essences, and wet tissues and other care products, to achieve the effects of moisturizing, allergy prevention, inflammation diminishing, repair and the like.

An external preparation composition used for preventing or treating symptoms or diseases related to dermatopathy caused by dryness, UV rays and aging such as wrinkles and sags of the skin, pigmentation of the skin, skin roughness and coarse texture and skin diseases such as psoriasis, lichen, ichthyosis, keratosis, Darier's disease, pustulosis, acne, eczema and atopic dermatitis. The external preparation composition comprises at least one of acyl glucosamine derivatives represented by the following Formula (I): wherein R1, R2, R3, R4 and R5 are defined; and X is any one of groups represented by the following Formulas (A) to (C): wherein Y, n and R6 are also defined.

Mixed vesicular system containing a nanoemulsion with bilayer nanovesicles mimicking noisome and liposome for the topical delivery of dithranol alone or together with salicylic acid to treat psoriasis, eczemas, dermatophytoses, alopecia areata and other dermatological diseases and methods for producing said system.

The medicine for treating dermatosis is prepared with five kinds of Chinese medicinal materials, including paris rhizome, Chinese goldthread, skullcap root, rhubarb and gromwell, and the recipe may have other four kinds of Chinese medicinal materials in certain weight proportion. It may be medicine powder, decoction, ointment or paste. The medicine has the functions of clearing away heat and toxic material, promoting blood circulation to disperse blood clots, eliminating swelling and pain, etc. and may be used in treating acne, bedsore, boil, eczema, dermatitis, burns, scalds and other dermatosis. It has the advantages of high healing effect, fast acting, no irritation to skin, etc.

The invention provides a novel herbal composition containing the extracts of the leaves and / or stem of <italic>Argemone mexicana < / highlight>plant, optionally containing the extracts of the fruits of <italic>Cuminum cyminum< / highlight>, which exhibits useful in vitro, in vivo and interesting immunological and pharmacological activities; a process for preparation thereof; and a method of treatment of psoriasis and related immunological and biological disorders by administration of the said novel herbal composition. The useful in vitro, in vivo and interesting immunological and pharmacological activities exhibited by the extracts and fractions of the leaves and / or stem of <italic>Argemone mexicana < / highlight>plant include immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFNgamma inhibition, IL-10 induction, keratinocyte proliferation inhibition, keratolytic activity, endothelial cell proliferation inhibition, inhibition of cell adhesion molecule expression such as ICAM-1, MEST inhibition, and enzymes inhibition such as p60src Tyrosine kinase, which are known to be involved in anti-psoriatic activity. The novel herbal composition(s) is useful in the treatment of various disorders, such as psoriasis including plaque psoriasis, gutatte psoriasis, pustular psoriasis and psoriasis of the nails; dermatitis and scleroderma; eczema; inflammatory disorders and other autoimmune diseases like psoriatic arthritis, rheumatoid arthritis, Crohn's disease, multiple sclerosis, irritable bowel disease, ankylosing spondilitis, systemic lupus erythremetosus and Sjogren's syndrome; allergies like asthma and chronic obstructive pulmonary disease and is safe, well-tolerated, non-toxic, with minimal and reversible adverse reactions or side effects, and most importantly, with minimal relapse or recurrence of the disease following completion of a treatment regimen. The invention also describes the presence of phosphodiesterase (III, IV and V) inhibition and 5-Lipoxygenase inhibition in the aqueous, ethanolic or aqueous-ethanolic extracts of fruits of <italic>Cuminum cyminum < / highlight>plant.

Orally administered sodium cromoglycate has been found to be effective in the treatment of allergic conditions such as asthma, general food allergies, ulcerative colitis, atopic eczema, chronic urticaria and irritable bowel syndrome if it is presented such that the sodium cromoglycate becomes bioavailable within 10 minutes of exposure to intestinal fluid. The sodium cromoglycate may be presented as enteric-coated tablets or individually enteric-coated pellets or microgranules packaged with disintegrant in a ratio of at least 1.2:1 disintegrant:sodium cromoglycate (w:w). Optionally, the patients are first selected to have a total serum IgE level of at least 150 iu / ml.

A cleanser composition composed of purified water, sodium laureth sulfate, zinc pyrithione, cocamidopropyl betaine, glycerol cocoate, polyquaternium-7, and a cross-linked polyacrylic acid polymer for topical application to an area affected by a skin disorder such as seborrheic dermatitis, perioral dermatitis, rosacea, acne, tinea versicolor, eczema and psoriasis.

The invention provides novel hypoallergenic and non-irritant medical skin care formulations being water-in-oil emulsions. The formulations are free from ingredients with a known allergenic potential, such as fragrances, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins, thus being particularly suitable for patients with sensitive dry skin. The skin care formulations of the invention are useful in the prophylaxis and treatment of dry, sensitive skin or in the therapy or therapy support of eczematous or psoriatic skin and exhibit favorable sensorial properties. The invention furthermore provides a method of manufacturing the novel hypoallergenic and non-irritant skin care formulations.

The invention discloses a traditional Chinese medicine composition for preventing and treating skin diseases, and a preparation method thereof. The composition consists of radix sophorae falvescentis, fructus cnidii, wild chrysanthemum flower, menthol and borneol, and is prepared into an external preparation according to a certain proportion. The composition can be prepared into medicines and health-care products, such as external lotion, liniment, ointment, tincture, effervescent granules, effervescent tablets, external wet tissue, shower cream and the like. The preparation has the efficacies of clearing away heat and toxic material, dispelling wind and arresting itching, removing dampness and destroying parasites, and is mainly used for cutaneous pruritus, eczema, dermatitis, morbid leukorrhea and pruritus vulvae, mosquito bites and the like caused by damp-heat stagnation.

The invention provides a method and composition for treating dermatoses by topical application of a composition containing an antihistamine, an NSAID and optionally a botanical medicinal compound. The compositions are useful for skin conditions such as inflammatory skin conditions, including eczema, atopic dermatitis, non-allergic dermatitis, psoriasis and rosacea, or any inflammation of the skin.

Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof:are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.

A composite Chinese medicine for treating skin itching and chronic eczema is prepared from 5 Chinese-medicinal materials including flavescent sophora root, liquorice root, borneol, etc. Its preparing process is also disclosed.

The invention provides a pharmaceutical preparation for treating skin diseases and a preparation method thereof. It is mainly prepared from the raw materials of S. Some or all of the Kochia scoparia medicinal materials are used in combination. Compared with the prior art, the formula provided by the present invention can be prepared into oral preparations or external preparations according to the conventional preparation process. Sexual skin diseases have a good curative effect, the total effective rate can reach more than 95%, and it is safe to use, has no toxic and side effects, and does not produce drug resistance. It is a safe, effective and quality-controllable treatment for itchy skin diseases. New medicine of traditional Chinese medicine.

The invention relates to a method for using alcaine 13-hexyl berberine, and relative lcaine 13-palmatine to prepare external the drug that resists dermopathy and psoriasis. And it has antibacterial activity and better treatment on eczema, etc. And its emulsion can treat psoriasis with similar effect of Simvastatin, without side effect.

The present invention generally relates to topical compositions, and particularly to a topical ointment for treatment of skin disorders and methods of use thereof The present invention recognizes that treatment of certain skin disorders can be more efficient, safe, and rapid-acting with few or no side effects. The present invention is particularly adaptable for treatment of a variety of skin disorders, such as for example, dermatitis (eczema), psoriasis and other forms of immuno-dysfunctional dermatitis. The present invention can be combined as supplement treatment to many available over-the counter and / or prescriptive products for treatment of skin disorders.

The invention provides a novel method of applying matrine to treating eczematous dermatitis, belonging to the field of medicines. The method is characterized by 1. adopting intravenous drip of matrine to treat eczematous dermatitis, 2. adopting intravenous drip of matrine to treat eczematous dermatitis in combination with oral administration of antihistamines, 3. adopting oral administration of matrine tablets or capsules to treat eczematous dermatitis and 4. applying matrine ointments to the wounded parts to externally treat eczematous dermatitis. Compared with the existing medicines and methods for treating eczematous dermatitis, the novel method has the effects that unexpected curative effects can be obtained and the cure rate is above 75%. The new method is an innovative idea of holistic treatment for treating eczematous dermatitis and has great medical significance.

Disclosed are compounds of formula II:wherein A is as defined by the specification. Also disclosed are compositions containing the esters and methods for their use in the regulation of skin atrophy and in the treatment of skin disorders such as dry skin, dandruff, acne and eczema.